Dune Medical Devices has announced the U.S. release of its MarginProbe System, which was approved by the FDA in January. The University of California, Irvine Medical Center was the first in the U.S. to deploy the system, which is used for tissue evaluation during early-stage breast cancer procedures.
Dune Medical's breast cancer device debuts in U.S.
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
Health Alliance Plan of Michigan
|Senior Vice-President Managed Care Mid-Atlantic Region||
Mercy Health System
|Associate Chief Financial Officer||
Commonwealth Care Alliance
|Assistant General Counsel, Regulatorya||
|Chief Operating Officer||
Health Plan of San Joaquin
|French Camp , CA|